Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 80

1.

Global incidence and profile of ameloblastoma: A systematic review and meta-analysis.

Hendra FN, Van Cann EM, Helder MN, Ruslin M, de Visscher JG, Forouzanfar T, de Vet HCW.

Oral Dis. 2019 Jan 6. doi: 10.1111/odi.13031. [Epub ahead of print] Review.

PMID:
30614154
2.

Radical vs conservative treatment of intraosseous ameloblastoma: Systematic review and meta-analysis.

Hendra FN, Natsir Kalla DS, Van Cann EM, de Vet HCW, Helder MN, Forouzanfar T.

Oral Dis. 2018 Dec 12. doi: 10.1111/odi.13014. [Epub ahead of print] Review.

PMID:
30548549
3.

Enhanced osteogenic activity by MC3T3-E1 pre-osteoblasts on chemically surface-modified poly(ε-caprolactone) 3D-printed scaffolds compared to RGD immobilized scaffolds.

Zamani Y, Mohammadi J, Amoabediny G, Visscher DO, Helder MN, Zandieh-Doulabi B, Klein-Nulend J.

Biomed Mater. 2018 Nov 13;14(1):015008. doi: 10.1088/1748-605X/aaeb82.

PMID:
30421722
4.

A review of the most promising biomarkers for early diagnosis and prognosis prediction of tongue squamous cell carcinoma.

Hussein AA, Forouzanfar T, Bloemena E, de Visscher J, Brakenhoff RH, Leemans CR, Helder MN.

Br J Cancer. 2018 Sep;119(6):724-736. doi: 10.1038/s41416-018-0233-4. Epub 2018 Aug 21.

PMID:
30131545
5.

StemBell therapy stabilizes atherosclerotic plaques after myocardial infarction.

Woudstra L, Meinster E, VAN Haren L, Kay AM, Koopman M, Belien JAM, Morrison MC, VAN Rossum AC, Helder MN, Juffermans LJM, Niessen HWM, Krijnen PAJ.

Cytotherapy. 2018 Sep;20(9):1143-1154. doi: 10.1016/j.jcyt.2018.05.006. Epub 2018 Aug 12.

PMID:
30107976
6.

Codelivery of doxorubicin and JIP1 siRNA with novel EphA2-targeted PEGylated cationic nanoliposomes to overcome osteosarcoma multidrug resistance.

Haghiralsadat F, Amoabediny G, Naderinezhad S, Zandieh-Doulabi B, Forouzanfar T, Helder MN.

Int J Nanomedicine. 2018 Jul 3;13:3853-3866. doi: 10.2147/IJN.S150017. eCollection 2018.

7.

Changes in Intervertebral Disk Mechanical Behavior During Early Degeneration.

Paul CPL, Emanuel KS, Kingma I, van der Veen AJ, Holewijn RM, Vergroesen PA, van de Ven PM, Mullender MG, Helder MN, Smit TH.

J Biomech Eng. 2018 Sep 1;140(9). doi: 10.1115/1.4039890.

PMID:
29801164
8.

Evaluation of a new biphasic calcium phosphate for maxillary sinus floor elevation: Micro-CT and histomorphometrical analyses.

Helder MN, van Esterik FAS, Kwehandjaja MD, Ten Bruggenkate CM, Klein-Nulend J, Schulten EAJM.

Clin Oral Implants Res. 2018 May;29(5):488-498. doi: 10.1111/clr.13146. Epub 2018 Apr 11.

9.

Osteocyte morphology and orientation in relation to strain in the jaw bone.

Wu V, van Oers RFM, Schulten EAJM, Helder MN, Bacabac RG, Klein-Nulend J.

Int J Oral Sci. 2018 Feb 26;10(1):2. doi: 10.1038/s41368-017-0007-5.

10.

Preparation of PEGylated cationic nanoliposome-siRNA complexes for cancer therapy.

Haghiralsadat F, Amoabediny G, Naderinezhad S, Forouzanfar T, Helder MN, Zandieh-Doulabi B.

Artif Cells Nanomed Biotechnol. 2018;46(sup1):684-692. doi: 10.1080/21691401.2018.1434533. Epub 2018 Feb 23.

PMID:
29475393
11.

Quantitative MRI in early intervertebral disc degeneration: T1rho correlates better than T2 and ADC with biomechanics, histology and matrix content.

Paul CPL, Smit TH, de Graaf M, Holewijn RM, Bisschop A, van de Ven PM, Mullender MG, Helder MN, Strijkers GJ.

PLoS One. 2018 Jan 30;13(1):e0191442. doi: 10.1371/journal.pone.0191442. eCollection 2018.

12.

Blood Vessel Formation and Bone Regeneration Potential of the Stromal Vascular Fraction Seeded on a Calcium Phosphate Scaffold in the Human Maxillary Sinus Floor Elevation Model.

Farré-Guasch E, Bravenboer N, Helder MN, Schulten EAJM, Ten Bruggenkate CM, Klein-Nulend J.

Materials (Basel). 2018 Jan 20;11(1). pii: E161. doi: 10.3390/ma11010161.

13.

EphA2 Targeted Doxorubicin-Nanoliposomes for Osteosarcoma Treatment.

Haghiralsadat F, Amoabediny G, Naderinezhad S, Nazmi K, De Boer JP, Zandieh-Doulabi B, Forouzanfar T, Helder MN.

Pharm Res. 2017 Dec;34(12):2891-2900. doi: 10.1007/s11095-017-2272-6. Epub 2017 Nov 6.

PMID:
29110283
14.

MRI and Additive Manufacturing of Nasal Alar Constructs for Patient-specific Reconstruction.

Visscher DO, van Eijnatten M, Liberton NPTJ, Wolff J, Hofman MBM, Helder MN, Don Griot JPW, Zuijlen PPMV.

Sci Rep. 2017 Aug 30;7(1):10021. doi: 10.1038/s41598-017-10602-9.

15.

Global incidence of oral and oropharynx cancer in patients younger than 45 years versus older patients: A systematic review.

Hussein AA, Helder MN, de Visscher JG, Leemans CR, Braakhuis BJ, de Vet HCW, Forouzanfar T.

Eur J Cancer. 2017 Sep;82:115-127. doi: 10.1016/j.ejca.2017.05.026. Epub 2017 Jun 24. Review.

PMID:
28654785
16.

A Novel Approach on Drug Delivery: Investigation of A New Nano-Formulation of Liposomal Doxorubicin and Biological Evaluation of Entrapped Doxorubicin on Various Osteosarcoma Cell Lines.

Haghiralsadat F, Amoabediny G, Sheikhha MH, Forouzanfar T, Helder MN, Zandieh-Doulabi B.

Cell J. 2017 Spring;19(Suppl 1):55-65. doi: 10.22074/cellj.2017.4502. Epub 2017 May 17.

17.

Static axial overloading primes lumbar caprine intervertebral discs for posterior herniation.

Paul CP, de Graaf M, Bisschop A, Holewijn RM, van de Ven PM, van Royen BJ, Mullender MG, Smit TH, Helder MN.

PLoS One. 2017 Apr 6;12(4):e0174278. doi: 10.1371/journal.pone.0174278. eCollection 2017.

18.

A comprehensive mathematical model of drug release kinetics from nano-liposomes, derived from optimization studies of cationic PEGylated liposomal doxorubicin formulations for drug-gene delivery.

Haghiralsadat F, Amoabediny G, Helder MN, Naderinezhad S, Sheikhha MH, Forouzanfar T, Zandieh-Doulabi B.

Artif Cells Nanomed Biotechnol. 2018 Feb;46(1):169-177. doi: 10.1080/21691401.2017.1304403. Epub 2017 Apr 4.

PMID:
28376641
19.

Noninvasive Measurement of Ear Cartilage Elasticity on the Cellular Level: A New Method to Provide Biomechanical Information for Tissue Engineering.

Bos EJ, van der Laan K, Helder MN, Mullender MG, Iannuzzi D, van Zuijlen PP.

Plast Reconstr Surg Glob Open. 2017 Feb 9;5(2):e1147. doi: 10.1097/GOX.0000000000001147. eCollection 2017 Feb.

20.

New liposomal doxorubicin nanoformulation for osteosarcoma: Drug release kinetic study based on thermo and pH sensitivity.

Haghiralsadat F, Amoabediny G, Sheikhha MH, Zandieh-Doulabi B, Naderinezhad S, Helder MN, Forouzanfar T.

Chem Biol Drug Des. 2017 Sep;90(3):368-379. doi: 10.1111/cbdd.12953. Epub 2017 Apr 12.

PMID:
28120466

Supplemental Content

Loading ...
Support Center